MedPath

Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam on Voluntary Subjects

Not Applicable
Recruiting
Conditions
Healthy
Pathology
Interventions
Device: MRI examination
Registration Number
NCT05218460
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The EDEN study will make it possible to evaluate one or more development phases (from design to validation through optimization) of a method or a technique on voluntary subjects, in normal or pathological condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
720
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All subjects will have an MRI examinationMRI examination-
Primary Outcome Measures
NameTimeMethod
Image quality based on standard imaging quality criteria6 months after the last inclusion

The image quality will be appreciated visually at least by a radiologist or a researcher.

Signal quality based on standard signal quality criteria6 months after the last inclusion

The signal quality will be appreciated visually at least by a radiologist or a researcher.

Secondary Outcome Measures
NameTimeMethod
Comparison of the Contrast to Noise Ratio obtained by the component of the MRI system under development and the reference situation.6 months after the last inclusion

Contrast to Noise Ratio will be measured in arbitrary units.

Comparison of blurring and artefacts obtained by the component of the MRI system under development and the reference situation.6 months after the last inclusion

Absence of blurring and artefacts will be assessed by at least one radiologist according to an ordinal scale (1 to 5 ; 1 is the worst score and 5 is the better score).

Comparison of the Signal to Noise Ratio obtained by the component of the MRI system under development and the reference situation.6 months after the last inclusion

ignal to Noise Ratio will be measured in arbitrary units.

Trial Locations

Locations (1)

CHRU de Nancy

🇫🇷

Nancy, France

© Copyright 2025. All Rights Reserved by MedPath